CytomX

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.

About CTMX

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W.

CEO

Sean A. McCarthy

CEOSean A. McCarthy

Employees

121

Employees121

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2010

Founded2010

Employees

121

Employees121

CTMX Key Statistics

Market cap

545.04M

Market cap545.04M

Price-Earnings ratio

5.81

Price-Earnings ratio5.81

Dividend yield

—

Dividend yield—

Average volume

2.48M

Average volume2.48M

High today

$3.50

High today$3.50

Low today

$3.30

Low today$3.30

Open price

$3.34

Open price$3.34

Volume

1.43M

Volume1.43M

52 Week high

$3.91

52 Week high$3.91

52 Week low

$0.40

52 Week low$0.40

CTMX News

TipRanks 2d

CytomX Therapeutics Advances CX-2051 Study in Solid Tumors

CytomX Therapeutics Inc. ((CTMX)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own CTMX. This list is generated using Robinhood data, and it’s not a recommendation.